Division of Endocrinology and Metabolism, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea.
Division of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
Endocrinol Metab (Seoul). 2020 Mar;35(1):165-176. doi: 10.3803/EnM.2020.35.1.165.
We evaluated the association of visceral-to-subcutaneous fat ratio (VSR) with nonalcoholic fatty liver disease (NAFLD) and advanced fibrosis degree based on noninvasive serum fibrosis markers in the general population with NAFLD.
This is a cross-sectional study, in 7,465 Korean adults who underwent health screening examinations. NAFLD was defined as fatty liver detected on ultrasonography, and visceral and subcutaneous abdominal fat was measured using computed tomography. We predicted fibrosis based on the fibrosis-4 (FIB-4) score and aspartate aminotransferase-to-platelet ratio index (APRI) and categorized the risk for advanced fibrosis as low, indeterminate, or high.
The multivariable-adjusted prevalence ratios for indeterminate to high risk of advanced fibrosis based on FIB-4, determined by comparing the second, third, and fourth quartiles with the first quartile of VSR, were 3.38 (95% confidence interval [CI], 0.64 to 17.97), 9.41 (95% CI, 1.97 to 45.01), and 19.34 (95% CI, 4.06 to 92.18), respectively. The multivariable-adjusted prevalence ratios for intermediate to high degree of fibrosis according to APRI also increased across VSR quartiles (5.04 [95% CI, 2.65 to 9.59], 7.51 [95% CI, 3.91 to 14.42], and 19.55 [95% CI, 9.97 to 38.34], respectively). High VSR was more strongly associated with the prevalence of NAFLD in nonobese subjects than in obese subjects, and the associations between VSR and intermediate to high probability of advanced fibrosis in NAFLD were stronger in obese subjects than in nonobese subjects.
High VSR values predicted increased NAFLD risk and advanced fibrosis risk with NAFLD, and the predictive value of VSR for indeterminate to high risk of advanced fibrosis was higher in obese subjects than in nonobese subjects.
我们评估了内脏-皮下脂肪比(VSR)与非酒精性脂肪性肝病(NAFLD)和非侵入性血清纤维化标志物在非酒精性脂肪肝患者中的相关性。
这是一项横断面研究,共纳入 7465 名接受健康筛查的韩国成年人。NAFLD 定义为超声检查发现的脂肪肝,通过计算机断层扫描测量内脏和皮下腹部脂肪。我们根据纤维化 4 (FIB-4)评分和天门冬氨酸氨基转移酶与血小板比值指数(APRI)预测纤维化,并将晚期纤维化的风险分为低、不确定和高。
根据 VSR,将 FIB-4 第二、三、四分位数与第一四分位数进行比较,得出的不确定到高风险的晚期纤维化多变量调整比值比分别为 3.38(95%可信区间 [CI],0.64 至 17.97)、9.41(95% CI,1.97 至 45.01)和 19.34(95% CI,4.06 至 92.18)。根据 APRI,中间到高纤维化程度的多变量调整比值比也随着 VSR 四分位数的增加而增加(5.04[95%CI,2.65 至 9.59]、7.51[95%CI,3.91 至 14.42]和 19.55[95%CI,9.97 至 38.34])。高 VSR 与非肥胖患者的 NAFLD 患病率相关性更强,与肥胖患者的 NAFLD 患者中中间到高概率的晚期纤维化的相关性更强。
高 VSR 值预测 NAFLD 风险和非酒精性脂肪肝患者的晚期纤维化风险增加,VSR 对晚期纤维化不确定到高风险的预测价值在肥胖患者中高于非肥胖患者。